HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Previous close
$0.70
Day range
$0.70 - $0.70
Year range
$0.51 - $0.80
Market cap
32.45M CAD
Avg Volume
36.27K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.44M | 68.19% |
Net income | -1.41M | -98.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.01M | -45.43% |
Total assets | 3.13M | -44.92% |
Total liabilities | 993.58K | 188.33% |
Total equity | 2.14M | — |
Shares outstanding | 46.31M | — |
Price to book | 14.00 | — |
Return on assets | -100.84% | — |
Return on capital | -128.95% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.41M | -98.55% |
Cash from operations | -829.86K | 58.42% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -833.37K | 46.32% |
Free cash flow | -316.04K | 82.62% |
About
Founded
2018
Headquarters
Website
